Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,617 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 and shielding: experiences of UK patients with lupus and related diseases.
Sloan M, Gordon C, Lever E, Harwood R, Bosley MA, Pilling M, Brimicombe J, Naughton F, Blane M, Walia C, D'Cruz D. Sloan M, et al. Among authors: gordon c. Rheumatol Adv Pract. 2021 Jan 21;5(1):rkab003. doi: 10.1093/rap/rkab003. eCollection 2021. Rheumatol Adv Pract. 2021. PMID: 33728396 Free PMC article.
The BILAG-2004 index is sensitive to change for assessment of SLE disease activity.
Yee CS, Farewell V, Isenberg DA, Griffiths B, Teh LS, Bruce IN, Ahmad Y, Rahman A, Prabu A, Akil M, McHugh N, Edwards C, D'Cruz D, Khamashta MA, Maddison P, Gordon C. Yee CS, et al. Among authors: gordon c. Rheumatology (Oxford). 2009 Jun;48(6):691-5. doi: 10.1093/rheumatology/kep064. Epub 2009 Apr 24. Rheumatology (Oxford). 2009. PMID: 19395542 Free PMC article.
Numerical scoring for the Classic BILAG index.
Cresswell L, Yee CS, Farewell V, Rahman A, Teh LS, Griffiths B, Bruce IN, Ahmad Y, Prabu A, Akil M, McHugh N, Toescu V, D'Cruz D, Khamashta MA, Maddison P, Isenberg DA, Gordon C. Cresswell L, et al. Among authors: gordon c. Rheumatology (Oxford). 2009 Dec;48(12):1548-52. doi: 10.1093/rheumatology/kep183. Epub 2009 Sep 24. Rheumatology (Oxford). 2009. PMID: 19779027 Free PMC article.
Numerical scoring for the BILAG-2004 index.
Yee CS, Cresswell L, Farewell V, Rahman A, Teh LS, Griffiths B, Bruce IN, Ahmad Y, Prabu A, Akil M, McHugh N, D'Cruz D, Khamashta MA, Isenberg DA, Gordon C. Yee CS, et al. Among authors: gordon c. Rheumatology (Oxford). 2010 Sep;49(9):1665-9. doi: 10.1093/rheumatology/keq026. Epub 2010 Feb 24. Rheumatology (Oxford). 2010. PMID: 20181671 Free PMC article.
The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients.
Yee CS, Farewell VT, Isenberg DA, Griffiths B, Teh LS, Bruce IN, Ahmad Y, Rahman A, Prabu A, Akil M, McHugh N, Edwards C, D'Cruz D, Khamashta MA, Gordon C. Yee CS, et al. Among authors: gordon c. Rheumatology (Oxford). 2011 May;50(5):982-8. doi: 10.1093/rheumatology/keq376. Epub 2011 Jan 18. Rheumatology (Oxford). 2011. PMID: 21245073 Free PMC article.
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales.
McCarthy EM, Sutton E, Nesbit S, Parker B, Jayne D, Griffiths B, Isenberg DA, Rahman A, Gordon C, D'Cruz DP, Rhodes B, Lanyon P, Vital EM, Yee CS, Edwards CJ, Teh LS, Akil M, McHugh NJ, Zoma A, Bruce IN; British Isles Lupus Assessment Group Biologics Register. McCarthy EM, et al. Among authors: gordon c. Rheumatology (Oxford). 2017 Jun 1;56(6):1041-1043. doi: 10.1093/rheumatology/kex044. Rheumatology (Oxford). 2017. PMID: 28431104 Free PMC article. No abstract available.
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales.
McCarthy EM, Sutton E, Nesbit S, Parker B, Jayne D, Griffiths B, Isenberg DA, Rahman A, Gordon C, D'Cruz DP, Rhodes B, Lanyon P, Vital EM, Yee CS, Edwards CJ, Teh LS, Akil M, McHugh NJ, Zoma A, Bruce IN; British Isles Lupus Assessment Group Biologics Register. McCarthy EM, et al. Among authors: gordon c. Rheumatology (Oxford). 2017 Jun 1;56(6):1049. doi: 10.1093/rheumatology/kex218. Rheumatology (Oxford). 2017. PMID: 28549192 Free PMC article. No abstract available.
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive Summary.
Gordon C, Amissah-Arthur MB, Gayed M, Brown S, Bruce IN, D'Cruz D, Empson B, Griffiths B, Jayne D, Khamashta M, Lightstone L, Norton P, Norton Y, Schreiber K, Isenberg D; British Society for Rheumatology Standards, Audit and Guidelines Working Group. Gordon C, et al. Rheumatology (Oxford). 2018 Jan 1;57(1):14-18. doi: 10.1093/rheumatology/kex291. Rheumatology (Oxford). 2018. PMID: 29029296 Free article. No abstract available.
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults.
Gordon C, Amissah-Arthur MB, Gayed M, Brown S, Bruce IN, D'Cruz D, Empson B, Griffiths B, Jayne D, Khamashta M, Lightstone L, Norton P, Norton Y, Schreiber K, Isenberg D; British Society for Rheumatology Standards, Audit and Guidelines Working Group. Gordon C, et al. Rheumatology (Oxford). 2018 Jan 1;57(1):e1-e45. doi: 10.1093/rheumatology/kex286. Rheumatology (Oxford). 2018. PMID: 29029350 Free article. No abstract available.
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register.
McCarthy EM, Sutton E, Nesbit S, White J, Parker B, Jayne D, Griffiths B, Isenberg DA, Rahman A, Gordon C, D'Cruz DP, Rhodes B, Lanyon P, Vital EM, Yee CS, Edwards CJ, Teh LS, Akil M, McHugh NJ, Zoma A, Bruce IN; British Isles Lupus Assessment Group Biologics Register. McCarthy EM, et al. Among authors: gordon c. Rheumatology (Oxford). 2018 Mar 1;57(3):470-479. doi: 10.1093/rheumatology/kex395. Rheumatology (Oxford). 2018. PMID: 29216396 Free PMC article.
2,617 results